200 mg GILEAD (Emtriva 200 mg)

Generic Name: emtricitabine

Pill with imprint 200 mg GILEAD is Blue & White, Capsule-shape and has been identified as Emtriva 200 mg. It is supplied by Gilead Sciences.

Emtriva is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Emtriva 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for 200 mg GILEAD

Emtriva

Generic Name:

emtricitabine

Imprint:

200 mg GILEAD

Strength:

200 mg

Color:

Blue & White

Size:

19.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Nucleoside reverse transcriptase inhibitors (NRTIs)

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Gilead Sciences

Inactive Ingredients:

microcrystalline cellulose
crospovidone
povidone
magnesium stearate
water
FD&C Blue No. 2
titanium dioxide
gelatin
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC Code	Labeler / Repackager
54868-4853	Physicians Total Care Inc. (repackager)
54569-5521	A-S Medication Solutions, LLC (repackager)
35356-0205	Lake Erie Medical and Surgical Supply (repackager)

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.